Sign In
Buy GILD
$125.05
+0.180 (+0.144%)
At Close: Jun 23, 2026
Gilead Sciences, Inc. (GILD) Q2 2025 Earnings Call Transcript
09:39pm, Thursday, 07'th Aug 2025
Gilead Sciences, Inc. (NASDAQ:GILD ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Andrew D. Dickinson - Chief Financial Officer Daniel P.
Gilead (GILD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
08:01pm, Thursday, 07'th Aug 2025
While the top- and bottom-line numbers for Gilead (GILD) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to
Gilead Sciences Q2: The New Drug That Could Change Everything
07:26pm, Thursday, 07'th Aug 2025
Gilead Sciences, Inc.'s HIV franchise, led by Biktarvy, ensures stable cash flows through 2033, providing long-term visibility and a strong competitive advantage. The launch of Yeztugo, a biannual PrE
Gilead Sciences (GILD) Tops Q2 Earnings and Revenue Estimates
06:40pm, Thursday, 07'th Aug 2025
Gilead Sciences (GILD) came out with quarterly earnings of $2.01 per share, beating the Zacks Consensus Estimate of $1.95 per share. This compares to earnings of $2.01 per share a year ago.
Gilead posts flat quarterly profit, raises full-year outlook
04:25pm, Thursday, 07'th Aug 2025
Gilead Sciences on Thursday reported flat quarterly earnings on slightly higher revenue and raised its full-year financial outlook due largely to better-than-expected sales of HIV drugs.
How To Earn $500 A Month From Gilead Sciences Stock Ahead Of Q2 Earnings
02:51pm, Thursday, 07'th Aug 2025
Gilead Sciences, Inc. GILD will release earnings results for the second quarter, after the closing bell on Thursday, Aug. 7.
Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?
12:51pm, Monday, 04'th Aug 2025
Let's look at five pharma and biotech companies, PFE, LLY, AMGN, GILD and NVO, which are scheduled to release their second-quarter 2025 results this week.
Seeking Clues to Gilead (GILD) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
10:20am, Monday, 04'th Aug 2025
Get a deeper insight into the potential performance of Gilead (GILD) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of
GILD Likely to Beat on Q2 Earnings: Buy, Sell or Hold the Stock?
09:01am, Monday, 04'th Aug 2025
GILD eyes Q2 gains as demand for HIV drugs holds strong despite pricing pressures and cell therapy headwinds. We recommend investors to wait and watch for now.
Measures laid out in letters to 17 companies would either have modest impact or face legal challenges, say industry experts.
Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb
08:31am, Friday, 01'st Aug 2025
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss news of President Trump ordering pharma companies to lower U.S. drug prices in the next 60 days, the move to tiered pricing glo
President Trump demands drugmakers slash prices within 60 days
06:54am, Friday, 01'st Aug 2025
CNBC's Joe Kernen reports on the latest news.
Trump pressures 17 pharma CEOs to cut US drug prices
02:28pm, Thursday, 31'st Jul 2025
U.S. President Donald Trump sent letters to the chief executives of 17 major pharmaceutical companies, urging immediate action to lower the cost of prescription drugs for Americans, the White House sa
Trump posts letters to 17 pharmaceutical companies about drug prices
02:19pm, Thursday, 31'st Jul 2025
CNBC's Angelica Peebles joins 'The Exchange' to discuss President Trump posting letters to 17 pharmaceutical companies about drug prices.
Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days
01:48pm, Thursday, 31'st Jul 2025
President Donald Trump said he asked major pharmaceutical companies to take steps to cut U.S. drug prices within the next 60 days. It comes after Trump in May signed an executive order reviving a cont
